We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

34 hedge funds and large institutions have $378M invested in ProQR Therapeutics in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more capital invested

Capital invested by funds: $80.8M → $378M (+$297M)

225% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 4

36% more funds holding

Funds holding: 25 → 34 (+9)

16.81% more ownership

Funds ownership: 34.68% → 51.49% (+17%)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

Holders
34
Holders Change
+9
Holders Change %
+36%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
13
Increased
8
Reduced
10
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
+$39.7M
2
RG
Redmile Group
California
+$15.4M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$13.8M
4
PA
Perceptive Advisors
New York
+$8.09M
5
O
OrbiMed
New York
+$7.81M

Top Sellers

Rank Fund Capital Flow
1
PVI
Pura Vida Investments
New York
-$2.28M
2
AG
Artal Group
Luxembourg
-$2.13M
3
JGC
J. Goldman & Co
New York
-$1.62M
4
Millennium Management
Millennium Management
New York
-$1.43M
5
SFM
Sphera Funds Management
Israel
-$1.01M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$420K +$231K +21,688 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$325K +$60.3K +5,670 +51%
PCM
28
Prelude Capital Management
New York
$324K -$323K -30,372 -64%
JGGDR
29
JGP Global Gestao de Recursos
Brazil
$302K +$166K +15,618 New
Wells Fargo
30
Wells Fargo
California
$229K -$21.3K -2,000 -14%
Walleye Trading
31
Walleye Trading
New York
$18K +$10K +944 New
Bank of America
32
Bank of America
North Carolina
$5K – – –
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$4K – – –
UBS Group
34
UBS Group
Switzerland
$4K +$2.4K +226 New
TRCT
35
Tower Research Capital (TRC)
New York
$3K +$1.55K +146 New
JGC
36
J. Goldman & Co
New York
– -$1.62M -222,284 Closed
Millennium Management
37
Millennium Management
New York
– -$1.43M -195,352 Closed
GBBWRPM
38
Genovese Burford & Brothers Wealth & Retirement Plan Management
California
– -$55K -7,500 Closed
CF
39
Centaurus Financial
California
– -$11K -1,500 Closed
1
2

PRQR Hedge Fund Activity: Q3 2018 in Review

34 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q3 2018, worth a combined $378M — up 367% from $80.8M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new PRQR positions and 4 closed out — a net gain of 9 holders — while 8 added to existing stakes and 10 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $39.7M. The largest seller was Pura Vida Investments, cutting an estimated $2.28M.

  • 34 institutional investors held ProQR Therapeutics (PRQR) as of Q3 2018, up from 25 in Q2 2018.
  • Funds reported $378M of ProQR Therapeutics stock for Q3 2018, up 367% quarter-over-quarter.
  • 13 funds opened new ProQR Therapeutics positions in Q3 2018 and 4 closed out, a net change of +9 holders.
  • The largest ProQR Therapeutics buyer in Q3 2018 was RTW Investments, an estimated $39.7M added.
  • The largest ProQR Therapeutics seller in Q3 2018 was Pura Vida Investments, an estimated $2.28M sold.

Based on aggregated 13F filings for Q3 2018.